.Innovent Biologics has actually produced the case that its own checkpoint inhibitor-cytokine blend ...
.A phase 3 trial of Daiichi Sankyo as well as Merck & Co.'s HER3-directed antibody-drug conjugate...
.Five months after Rakovina Therapeutics turned towards artificial intelligence, the cancer-focused ...
.Ascendis Pharma has become a prospective threat to BioMarin's Voxzogo, disclosing period 3 growth d...
.Though Alkeus Pharmaceuticals' dental eye condition property fell short to dramatically lessen geog...
.With a trio of biotechs striking the Nasdaq on Friday, it was very easy to skip a smaller-scale pub...
.Immune checkpoint inhibitors are the superheroes of cancer cells treatment. Drugs like Bristol Myer...
.Invite to this week's Chutes & Ladders, our roundup of notable leadership hirings, firings and a...
.Regeneron is back along with lasting follow-up for its LAG-3 prevention and PD-1 inhibitor combinat...
.AstraZeneca has discussed an early check out the efficiency of its own in-house antibody-drug conju...